Press Releases

• Engage Therapeutics Announces $23 Million Series A Financing to Advance Phase 2b Development of Novel Epileptic Seizure Rescue Therapy 09/27/2017

For Media Inquiries, please contact:
Margaret S. Bonilla
JPA Health Communications
mbonilla@jpa.com
617-657-1301